Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04567706

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Analysis of the Tumor Microenvironment and Immune Response in Malignant Melanoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.

Detailed description

PRIMARY OBJECTIVE: I. Facilitate studies aimed at investigating new prognostic markers and potentially therapeutic therapies in malignant melanoma. OUTLINE: Patients undergo collection of blood samples at the time of the initial diagnostic work-up, and possibly prior to the initiation of surgery, chemotherapy, immunotherapy, or radiation therapy, at tumor progression or recurrence, and annually during routine follow-up (no more than 4 blood draws per year). Patients may also undergo collection of tissue sample during standard of care surgical or radiologic procedures. Healthy individuals undergo collection of blood samples up to 4 times over 1 year.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo collection of blood and tissue samples

Timeline

Start date
2013-05-07
Primary completion
2027-10-31
Completion
2027-10-31
First posted
2020-09-28
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04567706. Inclusion in this directory is not an endorsement.